Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by GoTogetheron May 02, 2017 7:51am

172 Views

Post# 26190864

RE:RE:RE:RE:Financials Released

Bionicjoke quoted :
" ... At the average selling price of $25,000 that comes to 16 TLC-2000's
sold all year in the States. ... "

You didn't do your homework correctly.

Well, the TLC-2000 you can buy them, or lease them :
Theralase TLC-2000 retails for between $20,000 (1 probe) to $40,000 (4 probe) or
$400 to $800 per month on a 5 year lease

Maybe the US market preferences lease contracts.
You should know that, you pretend to know everything.
But, as a born liar you leave this out, aren't you ?

EOM.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario